Aegerion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

AEGR 30.55 -0.09 (-0.29%)
price chart
Aegerion Pharmaceuticals, Inc. Prices $300 Million Convertible Senior Notes ...
Aegerion Pharmaceuticals, Inc. AEGR, -0.29% today announced the pricing of its offering of $300 million aggregate principal amount of 2.00% convertible senior notes due 2019 to persons that they reasonably believe to be qualified institutional buyers ...
Related articles »  
Avatier Selected by Rare Disease Specialists Aegerion Pharmaceuticals, Inc ...
SAN RAMON, CA, Aug 25, 2014 (Marketwired via COMTEX) -- Aegerion Pharmaceuticals, Inc., a publicly-traded biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare ...
Related articles »  
Today's Perilous Reversal Stock: Aegerion Pharmaceuticals (AEGR)
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.
3 Stocks Catch Wall Street's Eye: Digital Ally, Inc. (NASDAQ:DGLY ...  Markets Emerging
Aegerion says FDA investigation into off-label marketing is closed  Boston Business Journal (blog)
Related articles »  
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio ...
On Tuesday, shares in Aegerion Pharmaceuticals Inc. traded between $30.37 and $31.38 before ending the session 0.92% higher at $30.72.
Related articles »  
Aegerion Pharmaceuticals, Inc. (AEGR) & The GEO Group Inc (GEO): Scopia ...
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a $900 million market cap biopharmaceutical ...
Why Need to Watch: Aegerion Pharmaceuticals (NASDAQ:AEGR), Ciber (NYSE ...  eFinance Hub
Investor Focus on New Offering- Aegerion Pharmaceuticals (NASDAQ:AEGR ...  eMarketsDaily
Related articles »  
Aegerion Pharmaceuticals Announces Resolution of Warning Letter for ...
Aegerion Pharmaceuticals, Inc. AEGR, +5.07% today announced that it has received a closeout letter from the Office of Prescription Drug Promotion (OPDP) signifying the resolution of the Warning Letter in regard to statements made about JUXTAPID� during ...
Aegerion Pharmaceuticals Is Still Significantly Overvalued (AEGR)
Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) was one of the top performers in the biotechnology sector last year, gaining more than 180%.
Related articles »  
Morning Buzz: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), J. C. Penney ...
On 12 AUG Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) announced the pricing of its offering of $300 million aggregate principal amount of 2.00% convertible senior notes due 2019 to persons that they reasonably believe to be qualified institutional ...
Morning Watch List: Aegerion (NASDAQ:AEGR), United States Steel (NYSE:X ...  WallStreet Scope
Related articles »  
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Aegerion Pharmaceuticals, Inc. AEGR, +0.10% a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on August 1, 2014, Aegerion granted ...
Related articles »  
Hot Watch List: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), ARM Holdings ...
On 19 AUG Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) CFO Mark J. Fitzpatrick acquired 1,150 shares of the stock in a transaction dated Tuesday.
Related articles »